C-peptide prevents and improves chronic Type I diabetic polyneuropathy in the BB/Wor rat.
about
Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamilyPhysiological effects and therapeutic potential of proinsulin C-peptideC-peptide and its C-terminal fragments improve erythrocyte deformability in type 1 diabetes patients.Diabetic neuropathy: mechanisms to managementThe Effects of Lycopene and Insulin on Histological Changes and the Expression Level of Bcl-2 Family Genes in the Hippocampus of Streptozotocin-Induced Diabetic Rats.New therapeutic and biomarker discovery for peripheral diabetic neuropathy: PARP inhibitor, nitrotyrosine, and tumor necrosis factor-{alpha}C-peptide: new findings and therapeutic implications in diabetes.C-peptide increases Na,K-ATPase expression via PKC- and MAP kinase-dependent activation of transcription factor ZEB in human renal tubular cells.C-peptide and diabetic neuropathy.The clinical potential of C-peptide replacement in type 1 diabetes.Coenzyme Q10 prevents peripheral neuropathy and attenuates neuron loss in the db-/db- mouse, a type 2 diabetes modelDiabetic neuropathy differs in type 1 and type 2 diabetes.Advanced Diabetic Neuropathy: A Point of no Return?Effect of C-peptide on diabetic neuropathy in patients with type 1 diabetesThe effects of C-peptide on type 1 diabetic polyneuropathies and encephalopathy in the BB/Wor-rat.C-Peptide effects on renal physiology and diabetes.The beneficial effects of C-Peptide on diabetic polyneuropathy.C-peptide and long-term complications of diabetes.Mechanisms of distal axonal degeneration in peripheral neuropathies.Pathological consequences of C-peptide deficiency in insulin-dependent diabetes mellitus.Alternatives to the Streptozotocin-Diabetic Rodent.C-peptide antioxidant adaptive pathways in β cells and diabetes.Autocrine C-peptide mechanism underlying INS1 beta cell adaptation to oxidative stress.C-Peptide replacement therapy in type 1 diabetes: are we in the trough of disillusionment?How the immunoassay transformed C-peptide from a duckling into a swan.Diabetic neuropathy: pathogenetic background, current and future therapies.ω-3 polyunsaturated fatty acids ameliorate type 1 diabetes and autoimmunityDynamic changes of neuroskeletal proteins in DRGs underlie impaired axonal maturation and progressive axonal degeneration in type 1 diabetes.Ligand-independent activation of peroxisome proliferator-activated receptor-gamma by insulin and C-peptide in kidney proximal tubular cells: dependent on phosphatidylinositol 3-kinase activity.Impaired glucose tolerance and insulinopenia in the GK-rat causes peripheral neuropathy.C-peptide increases forearm blood flow in patients with type 1 diabetes via a nitric oxide-dependent mechanism.Proinsulin C-peptide replacement in type 1 diabetic BB/Wor-rats prevents deficits in nerve fiber regeneration.Experimental rat models of types 1 and 2 diabetes differ in sympathetic neuroaxonal dystrophy.Modulatory effect of the PDE-5 inhibitor sildenafil in diabetic neuropathy.Methylglyoxal Disrupts Paranodal Axoglial Junctions via Calpain Activation.A 9-Month Toxicity and Toxicokinetic Assessment of Subcutaneous Pegylated Human C-peptide (CBX129801) in Cynomolgus Monkeys.
P2860
Q24558912-2C0F097C-BFC9-4BDA-98F2-4528FA7EFA31Q27012286-74DF24CA-B610-4A12-AC0D-DE628889D2F7Q33335159-07AE0B0B-FB7F-4E09-A02E-1D14DC158B28Q33554384-52679CEE-9479-4033-A807-D62946CEB61FQ33800689-B002555D-252F-4A78-9479-3C19130486BBQ33874485-C5B18D41-F5D9-4528-AE34-7C96DF8D2309Q33979590-974F2585-39E4-4A57-90A4-6BC6FDF71C5FQ34097615-C0A4F81E-0BB7-4D61-99E2-82168029A1F5Q35207611-BD78A8DB-3337-41F6-88B2-33AB15B99C0BQ35857755-DFB908E1-8DB4-4CA9-991A-426DACEFFA90Q36535440-A413FB28-A04B-4A07-B9DB-44F549B9CDA6Q36675877-2B314D94-CEA5-401A-9726-2362ED25D0B5Q36814825-2CE89689-4A14-4F36-9143-46C8E1B8726DQ37113466-0AD29EE4-B202-4C34-9C51-CF4F9A3B70CDQ37147785-D5EC706D-6BDD-4909-A625-E75E7E1D28C6Q37176072-7991653D-9532-48BB-BD64-78E1EC03272EQ37663812-48A68A3F-2F3D-4DDC-9071-B1A8C4617AC8Q37815562-A3B3D1A2-F071-4C4A-8E7C-B877048F2C70Q38330759-A884D20C-6D19-450C-B590-3AA16414FA87Q38356851-F46BE5CB-1FE4-4890-BE2B-DF1FDE0BAEE8Q38822212-0B245AA2-DB0A-48CE-8909-F7E6CE48431DQ38850708-E6F0AFF9-CCD6-4E86-9847-C82A3A9DCBE2Q39031176-D0D17F5C-6E8F-458D-83B0-3C25EAB825BEQ39420435-31973DBF-978D-40F7-8CCE-FB98BD3CEA3DQ39664344-11423606-48D8-4A32-9FC9-40A59B82B351Q40678882-4171B24D-05FD-48B3-97C8-073D2B7D63FAQ41880842-036BA231-5EDB-4B07-8FCB-2D0608A4D681Q41945335-245A4107-A185-4533-8548-75B5DCDBE9AEQ42467751-6D4BF3E3-D3C8-4E64-97EC-228CA77FA034Q44240871-2D856D8D-6B34-410A-9103-963DDD326CC0Q44473621-4456FC5D-6D03-4A7B-9CED-57BCB8527ECEQ44538902-991C04A1-6F67-4A72-AA44-C8B2295FE1F6Q44937306-2F53D552-298C-42DD-978F-8842D4A1E8BBQ45081554-1A8FB071-2122-4F15-8DE6-0468ADD90378Q52691523-DFE3C052-3D2A-4DFD-8390-E14E7736D6CBQ53453850-35B67FCA-FEDD-4E7C-BC88-F66FB6A9794B
P2860
C-peptide prevents and improves chronic Type I diabetic polyneuropathy in the BB/Wor rat.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
C-peptide prevents and improves chronic Type I diabetic polyneuropathy in the BB/Wor rat.
@ast
C-peptide prevents and improves chronic Type I diabetic polyneuropathy in the BB/Wor rat.
@en
C-peptide prevents and improves chronic Type I diabetic polyneuropathy in the BB/Wor rat.
@nl
type
label
C-peptide prevents and improves chronic Type I diabetic polyneuropathy in the BB/Wor rat.
@ast
C-peptide prevents and improves chronic Type I diabetic polyneuropathy in the BB/Wor rat.
@en
C-peptide prevents and improves chronic Type I diabetic polyneuropathy in the BB/Wor rat.
@nl
prefLabel
C-peptide prevents and improves chronic Type I diabetic polyneuropathy in the BB/Wor rat.
@ast
C-peptide prevents and improves chronic Type I diabetic polyneuropathy in the BB/Wor rat.
@en
C-peptide prevents and improves chronic Type I diabetic polyneuropathy in the BB/Wor rat.
@nl
P2093
P356
P1433
P1476
C-peptide prevents and improves chronic Type I diabetic polyneuropathy in the BB/Wor rat.
@en
P2093
P2888
P304
P356
10.1007/S001250100570
P50
P577
2001-07-01T00:00:00Z
P5875
P6179
1025157329